This is the consolidated view of findings. Click the Citation IDs or 'see details →' on any item for the full details for each finding.
Counsel relying on an AI summary of the January 28, 2026 correction notice would know a correction was issued but not which appendix it reinstated — meaning any opinion addressing the status of the suitability guidance under §§23.434 and 23.440 could be drafted without recognizing that Appendix A to Subpart H had a period of uncertain status. For swap dealers making recommendations to counterparties or special entities, that appendix is the operative interpretive authority; an opinion that doesn't register its momentary removal and restoration is missing a material fact in the compliance timeline.
The cited sources AI tools produced for this question included a fabricated URL, compounding the verification risk.
An opinion premised on Staff Letter 25-49 covering ITBC swaps on US SEFs and DCMs — rather than Eligible UK Trading Venues authorized by the FCA — is simply wrong on the instrument's jurisdictional scope. For a firm with UK execution flow, this error would produce a compliance gap: the letter's relief applies to a specific category of cross-border transactions, and misidentifying that category means the client either fails to claim available relief or applies it to transactions it doesn't cover.
Because the AI only retracted under direct challenge, a practitioner who does not already know the correct answer has no way to detect the error from the AI's initial response alone.
Advising a swap dealer that PTMMM disclosure is now eliminated for cleared CDS — on the basis that the rule eliminated the requirement 'in its entirety' — overstates the change. Cleared swaps were already outside §23.431(a)(3)'s scope before the December 2025 rule; the elimination restructured the provision for uncleared swaps, FX forwards, and FX swaps.
An opinion that presents the PTMMM repeal as product-agnostic would misrepresent the pre-existing regulatory baseline, potentially causing a client to attribute compliance relief to the new rule that was already present under the prior framework — a material misstatement in any regulatory history analysis or sign-off letter.